Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Naive Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT01684397
What this trial is testing

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer
Roswell Park Cancer Institute 51
Post-approval studies (Phase 4)Study completedNCT00552240
What this trial is testing

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Who this might be right for
HIV Infections
Boehringer Ingelheim 154
Testing effectiveness (Phase 2)Study completedNCT00316589
What this trial is testing

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 581
Testing effectiveness (Phase 2)Study completedNCT00263276
What this trial is testing

A Trial of BMS-512148 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
AstraZeneca 389
Not applicableStudy completedNCT02113852
What this trial is testing

Study of Blood, Tumor and Adjacent Normal Tissue Samples From Chinese Smoking Induced Lung Cancer Patients

Who this might be right for
Non Small Cell Lung Cancer
Guangdong Association of Clinical Trials 250
Testing effectiveness (Phase 2)UnknownNCT01242787
What this trial is testing

Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
LG Life Sciences 115
Not applicableStudy completedNCT00333892
What this trial is testing

Leukapheresis to Obtain Lymphocytes for Studies on Antiretroviral Naive HIV-infected Patients

Who this might be right for
Human Immunodeficiency Virus
Canadian Immunodeficiency Research Collaborative 220
Testing effectiveness (Phase 2)Study completedNCT01648517
What this trial is testing

Genotype-Driven Treatment of Advanced Non-small Cell Lung Cancer Based on mRNA Expression of ERCC1 & RRM1 as First-line Chemotherapy

Who this might be right for
Non-small Cell Lung Carcinoma
Yonsei University 60
Testing effectiveness (Phase 2)Looking for participantsNCT05384691
What this trial is testing

Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions

Who this might be right for
Myelodysplastic SyndromesAnemia
University of Leipzig 213
Not applicableUnknownNCT03579485
What this trial is testing

An Observational Retrospective Database Analysis to Evaluate Raltegravir Based-regimens, Including NUC-sparing Regimens, in Aged HIV Patients.(RalAge)

Who this might be right for
Hiv
Azienda Policlinico Umberto I 90
Large-scale testing (Phase 3)Study completedNCT02163759
What this trial is testing

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Ulcerative Colitis
Hoffmann-La Roche 358
Not applicableUnknownNCT01151397
What this trial is testing

Does 3 Months Therapy With Vitamin D + Peg + Ribavirin Improve Sustained Virologic Response (SVR) in Genotype 2, 3 Chronic Hepatitis C Patients?

Who this might be right for
Chronic Hepatitis C
Ziv Hospital 60
Not applicableStudy completedNCT03137797
What this trial is testing

Cohort of Patients Naive of Antiretroviral Treatment at Enrollment

Who this might be right for
HIV Infection
ANRS, Emerging Infectious Diseases 800
Early research (Phase 1)Ended earlyNCT04964505
What this trial is testing

Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Brian Jonas 16
Early research (Phase 1)Study completedNCT00856154
What this trial is testing

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Who this might be right for
HIV Infections
Statens Serum Institut 12
Testing effectiveness (Phase 2)Study completedNCT02879994
What this trial is testing

Pembrolizumab in Treating Patients With EGFR Mutant, Tyrosine Kinase Inhibitor Naive Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung CancerStage IV Non-Small Cell Lung Cancer
Jonsson Comprehensive Cancer Center 11
Testing effectiveness (Phase 2)Looking for participantsNCT07514169
What this trial is testing

The Efficacy and Safety of Pola-ZR-Glo in Older Treatment-naive Patients With LBCL

Who this might be right for
Large B-Cell Lymphoma (LBCL)
Ruijin Hospital 30
Large-scale testing (Phase 3)Study completedNCT00279045
What this trial is testing

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 4,426
Testing effectiveness (Phase 2)Study completedNCT00919061
What this trial is testing

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
Memorial Sloan Kettering Cancer Center 39
Testing effectiveness (Phase 2)Looking for participantsNCT07587515
What this trial is testing

Phase 1b/2a Study of EYC-0305 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular (Wet) Age-Related Macular Degeneration
Eyconis INC. 30
Next Page